- Product Details
Keywords
- TAK 285 manufacturer
- TAK 285 supplier
- TAK 285 seller
Quick Details
- ProName: TAK 285
- CasNo: 871026-44-7
- Molecular Formula: C26H25ClF3N5O3
- Application: only for research
- DeliveryTime: 2 weeks
- PackAge: according to the request of customer
- Port: Ji nan;
- ProductionCapacity: 1 Kilogram/Month
- Purity: 99%
- Storage: Low temperature dry and shady
- Transportation: according to the request of customer
- LimitNum: 1 Gram
Superiority
We have been providing over 1000 products including molecular targeted anticancer drugs, cell signaling pathway inhibitors,
pharmaceutical intermediates, and heterocyclic compounds, and quality services including custom synthesis, transfer of new
drug patent and technology, technical cooperation, and process optimization.
Details
Year Establishment: 2008
Location: At one of the largest National Technical Integrated Drug Discovery Platforms in the High-Tech Zone of Jinan City
Our company was founded by a core group of top overseas pharmaceutical chemists, medical scientists business
management experts
We have built up solid cooperation with over twenty oversea companies over one hundred domestic companies
since the foundation
Specifications:
Name TAK 285
Synonyms N-[2-[4-[[3-Chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]amino]-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-3-methylbutanamide
Molecular Formula C26H25ClF3N5O3
Molecular Weight 547.96
CAS Registry Number 871026-44-7
Applications:
TAK-285 is a novel dual HER2 EGFR inhibitwith IC50 of 17 nM 23 nM, respectively.